Timely confirmation of gastro-esophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations - PubMed
. 2008 May;24(5):1317-27.
doi: 10.1185/030079908x280680. Epub 2008 Mar 27.
Affiliations
- PMID: 18377705
- DOI: 10.1185/030079908x280680
Timely confirmation of gastro-esophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations
W C Lee et al. Curr Med Res Opin. 2008 May.
Abstract
Background: Current guidelines recommend the use of pH monitoring to confirm the diagnosis of acid reflux in patients with a normal endoscopy. This analysis evaluated the financial impact of pH monitoring with the wireless pH capsule on a managed care organization (MCO) in the United States.
Methods: A decision model was constructed to project total 1-year costs to manage GERD symptoms with and without the adoption of wireless pH capsules in a hypothetical MCO with 10 000 eligible adult enrollees, of whom 600 presented with GERD-like symptoms. Costs of GERD diagnosis, treatment, and symptom management for those in whom a GERD diagnosis was ruled out by pH monitoring were assessed. The incremental per-member-per-month (PMPM) and per-treated-member-per-month (PTMPM) costs were the primary outcomes. Data sources included literature, expert input, and standardized fee schedules.
Results: An increase of 10 percentage points in the use of pH monitoring with wireless pH capsules yielded incremental PMPM and PTMPM costs of $0.029 and $0.481, respectively. The costs of proton pump inhibitor (PPI) therapy to the plan dropped to $236,363 from $238,086, while increases were observed in pH monitoring (from $16 739 to $21 973) and non-GERD therapy costs (from $1392 to $1740). The results were sensitive to the percentage of patients requiring repeat endoscopy before wireless pH monitoring and the cost of PPIs.
Conclusions: Timely and increased use of pH monitoring as recommended in published guidelines leads to less unnecessary use of PPIs with a modest budgetary impact on health plans.
Similar articles
-
Schey R, Alla SP, Midani D, Parkman HP. Schey R, et al. Rev Gastroenterol Mex. 2017 Oct-Dec;82(4):277-286. doi: 10.1016/j.rgmx.2016.12.007. Epub 2017 Apr 3. Rev Gastroenterol Mex. 2017. PMID: 28385467 English, Spanish.
-
Kleiman DA, Beninato T, Bosworth BP, Brunaud L, Ciecierega T, Crawford CV Jr, Turner BG, Fahey TJ 3rd, Zarnegar R. Kleiman DA, et al. J Gastrointest Surg. 2014 Jan;18(1):26-33; discussion 33-4. doi: 10.1007/s11605-013-2327-x. Epub 2013 Nov 9. J Gastrointest Surg. 2014. PMID: 24214090
-
Afaneh C, Zoghbi V, Finnerty BM, Aronova A, Kleiman D, Ciecierega T, Crawford C, Fahey TJ 3rd, Zarnegar R. Afaneh C, et al. Surg Endosc. 2016 Aug;30(8):3454-60. doi: 10.1007/s00464-015-4629-4. Epub 2015 Nov 4. Surg Endosc. 2016. PMID: 26537906
-
Vela MF. Vela MF. Gastrointest Endosc Clin N Am. 2014 Oct;24(4):655-66. doi: 10.1016/j.giec.2014.07.002. Epub 2014 Jul 30. Gastrointest Endosc Clin N Am. 2014. PMID: 25216910 Review.
-
Ofman JJ, Dorn GH, Fennerty MB, Fass R. Ofman JJ, et al. Aliment Pharmacol Ther. 2002 Feb;16(2):261-73. doi: 10.1046/j.1365-2036.2002.01167.x. Aliment Pharmacol Ther. 2002. PMID: 11860409 Review.
Cited by
-
Modern diagnosis of GERD: the Lyon Consensus.
Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Gyawali CP, et al. Gut. 2018 Jul;67(7):1351-1362. doi: 10.1136/gutjnl-2017-314722. Epub 2018 Feb 3. Gut. 2018. PMID: 29437910 Free PMC article. Review.
-
Yadlapati R, Masihi M, Gyawali CP, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE. Yadlapati R, et al. Gastroenterology. 2021 Jan;160(1):174-182.e1. doi: 10.1053/j.gastro.2020.09.013. Epub 2020 Sep 16. Gastroenterology. 2021. PMID: 32949568 Free PMC article. Clinical Trial.
-
Gawron AJ, Rothe J, Fought AJ, Fareeduddin A, Toto E, Boris L, Kahrilas PJ, Pandolfino JE. Gawron AJ, et al. Clin Gastroenterol Hepatol. 2012 Jun;10(6):620-5; quiz e57. doi: 10.1016/j.cgh.2012.02.012. Epub 2012 Feb 22. Clin Gastroenterol Hepatol. 2012. PMID: 22366177 Free PMC article.
-
Budget-impact analyses: a critical review of published studies.
Orlewska E, Gulácsi L. Orlewska E, et al. Pharmacoeconomics. 2009;27(10):807-27. doi: 10.2165/11313770-000000000-00000. Pharmacoeconomics. 2009. PMID: 19803537 Review.
-
Park EY, Choi MG, Baeg M, Lim CH, Kim J, Cho Y, Park J, Lee I, Kim S, Choi K. Park EY, et al. Dig Dis Sci. 2013 Oct;58(10):2933-9. doi: 10.1007/s10620-013-2728-4. Epub 2013 Jun 14. Dig Dis Sci. 2013. PMID: 23765257
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical